APPLICATIONS PUBLISHED 21 JULY 2004
Published: 1-Feb-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Fondant-based pharmaceutical compsn
McNeil-PPC 1438018*
Kit for the preparation of a pharmaceutical compsn
PARI GmbH Spezialisten fuer effektive Inhalation 1438019*
Topical compsns and methods for treating pain
EpiCept 1438020*
Methods and apparatus for extrusion of vesicles at high pressure
Esperion Therapeutics 1438021*
Drug delivery system for controlled therapy
Vista Scientific 1438022*
Novel process
Glaxo Group 1438023*
Process for dispersing a fluid in solid particles
Dow Global Technologies 1438024*
Method for the production of active ingredient-containing pellets
Roehm 1438025*
Taste-masking spill-resistant formulation
Tero Pharmaceutical Industries 1438026*
Methods of treatments using a gastric retained losartan dosage
DepoMed 1438027*
Modified release dosage forms
McNeil-PPC 1438028*
Method and system for non-vascular sensor implantation
Medtronic Minimed 1438029*
Modified release dosage forms
McNeil-PPC 1438030*
Orally administered liquid compsns comprising guaifenesin and a polyalkylene block copolymer
Procter & Gamble 1438031*
Production of starch-gel-based shaped bodies
Innogel 1438032*
Hard capsules based on polysaccharides and method for the production thereof
Innogel 1438033*
Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
Gruenenthal 1438034*
Pharmaceutical compsns for the treatment of urinary disorders
Pharmacia 1438035*
Use of sulphonamide derivatives as pharmaceutical compounds
Eli Lilly 1438036*
Methods for treating dry eye by a combination of an anti-inflammatory steroid and a MUC-1 secretagogue
Alcon 1438037*
Method and compsn for preventing or reducing the symptoms of insulin resistance syndrome
Interhealth Nutraceuticals 1438038*
Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anticancer agent for therapeutic use in cancer treatment
Societe de Conseils de Recherche et d'Applications Scientifiques (SCRAS) 1438039*
Pharmaceutical compsns comprising mycophenolic acid or mycophenolate salt
Novartis 1438040*
Spermicides
SSL International 1438041*
Polymaleimide compounds and their medical use
SSL International 1438042*
Method of reducing type II diabetes in high risk patients
Aventis Pharma Deutschland 1438043*
Bis-heteroaryl alkanes as therapeutic agents
Transtech Pharma 1438044*
Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake
Biovitrum 1438045*
Thiazole benzamide derivatives and pharmaceutical compsns for inhibiting cell proliferation, and methods for their use
Agouron Pharmaceuticals 1438046*
Compounds for reducing excessive intake of food
Boehringer Ingelheim Pharma 1438047*
1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
Boehringer Ingelheim Pharma 1438048*
Substituted 4-phenyl-4-(imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
Janssen Pharmaceutica 1438049*
Irinotecan for treatment of cancer
Epidauros Biotechnologie 1438050*
An enantiomerically pure diaryl-methylpiperazine and methods of using same
Ardent Pharmaceuticals 1438051*
Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
Boehringer Ingelheim Pharma GmbH; Boehringer Ingelheim Pharmaceuticals Inc; Boehringer Ingelheim International GmbH 1438053*
Methods and compsns for treating flaviviruses and pestiviruses using 4'-modified nucleoside
Idenix (Cayman); Centre National de la Recherche Scientifique (CNRS) 1438054*
D-tagatose as an anti-biofilm agent
Spherix 1438055*
Drug for treating a fibrotic disease through RNA interference
Ribopharma 1438056*
Pine cone extracts and uses thereof
Tanaka, Akiko; Jessip, John; Bradley, William 1438057*
Extract of Ceratonia siliqua leaves and pods containing polyphenols with antioxidant and antitumour activities
Baraldi, Mario 1438058*
Compsn containing horse chestnut extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
Angiolab, Research Centre for Biomedicinal Resources; Kim, Min-Young 1438059*
Prevention and treatment of restenosis by local administration of drug
Esperion Therapeutics 1438060*
Copolymers for suppression of autoimmune diseases, and methods of use
President and Fellows of Harvard College 1438061*
Methods and compsns for treating dermal lesions
The General Hospital Corp 1438062*
Modulation of physiological processes and agents useful for same
The Mental Health Research Institute of Victoria 1438063*
A method for identification and development of therapeutic agents
Epipop 1438064*
An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions
Strauss, Bradley 1438065*
Incapacitated whole-cell immunogenic bacterial compsns
Gangagen 1438066*
Autologous growth factor cocktail compsn, method of production and use
Verigen 1438067*
Antibody inhibitors of GDF-8 and uses thereof
Wyeth 1438068*
Enzyme inhibitors for inactivating allergens
Molecular Skincare 1438069*
Treating vascular disease by inhibiting toll-like receptor-4
Cedars-Sinai Medical Centre 1438070*
Therapies for treating respiratory diseases
Glaxo Group 1438071*
Polysaccharide-based network and method for the production thereof
Innogel 1438072*
Polyoxyalkylenes conjugates as enzyme inhibitors
Procter & Gamble 1438073*
Adjuvant compsns
Chiron 1438074*
Methods and compsns relating to restricted expression lentiviral vectors and their applications
Institut Clayton de la Recherche 1438075*
Radiopharmaceutical agent for the treatment of early stage cancer
Dow Global Technologies 1438076*
Methods of sterilising biological materials containing non-aqueous solvents
Clearant 1438077*
Compsn consisting of a polymer containing amino groups and an aldehyde containing at least three aldehyde groups
Aesculap 1438079*
Antibiotic calcium phosphate coating
Howmedica Osteonics 1438080*
